A Better Treatment for Cat Allergies?
An NIH study found an experimental approach added to allergy shots—a standard cat allergy treatment—made it more effective and faster acting, and the benefits persisted for a year after treatment ended.
Bionic Pancreas Improves Type 1 Diabetes Management
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose...
Two Diabetes Drugs Outperformed Others in Clinical Trial
In a large, NIDDK-funded clinical trial comparing commonly used type 2 diabetes medications, researchers found that insulin glargine and liraglutide performed the best of four medications FDA-approved to maintain blood glucose levels in the recommended range.
Heart Medication Shows Potential for Treating Alcohol Use Disorder
A new NIH study has found that a medication for heart problems and high blood pressure may also be effective for treating alcohol use disorder (AUD).
Steroid Treatment May Improve Outcomes in Preterm Infants
Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a recent NIH study funded by NICHD and NCATS.
Novel Imaging Approach Reveals Details About Rare Eye Disease
NEI intramural researchers have shown for the first time how cells across different tissue layers in the eye are affected in people with choroideremia, a rare genetic disorder that leads to blindness.
Stimulation Improves Memory in Older Adults
A noninvasive stimulation technique targeting specific brain regions resulted in month-long memory improvements in seniors who participated in a recent study.
Bronchodilators Don’t Relieve Smoking-Related Symptoms in People Without COPD
NIH researchers have found that dual bronchodilators—long-lasting inhalers that relax the airways and make it easier to breathe—do little to help people who have respiratory symptoms related to smoking but who do not have chronic obstructive pulmonary disease (COPD).
Novel Blood Test Evaluates Severity in Rare Lung Disease
NIH researchers have found that a novel blood test can easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability. PAH is a rare, life-threatening condition that causes unexplained high blood pressure in the lungs.